Decreased tumor expression of Class I MHC molecules, ligands for NK inhibitor receptors, is associated with longer metastasis-free survival (53), while the loss of NK activator receptors (i.e., MIC-A and MIC-B) is associated with tumor progression (54). This evidence concerns the gene MICA and neoplasm.